Snap-8
Acetyl Octapeptide-3 / SNAP-8 Peptide
SNAP-8 (Acetyl Octapeptide-3, also marketed as Acetyl Glutamyl Heptapeptide-1) is a topical cosmetic peptide consisting of eight amino acids that modulates the SNARE complex responsible for neurotransmitter release at the neuromuscular junction. Developed by Lipotec as an extension of the hexapeptide Argireline concept, SNAP-8 is marketed as a topical alternative to botulinum toxin for reducing expression lines and wrinkles. It competitively inhibits SNARE complex formation, theoretically reducing muscle contraction intensity and thereby diminishing dynamic wrinkles.
作用機序
Octapeptide that mimics the N-terminal of SNAP-25, a key protein in the SNARE complex responsible for neurotransmitter release at neuromuscular junctions. Competitively inhibits SNARE complex formation, reducing muscle contraction intensity and thereby reducing expression lines.
研究プロトコル
研究目的のみで使用。医療アドバイスではありません。
Topical application only. Used at 3-10% concentration in serums applied twice daily to expression-line areas (forehead, crow's feet, glabella). Not injected. Continuous use required for maintained effect.
研究ノート
Clinical Research Status
SNAP-8 has been evaluated in manufacturer-sponsored clinical studies showing wrinkle depth reduction of up to 63% after 28 days of regular application at concentrations of 3-10% in cream formulations. Independent peer-reviewed clinical data is limited compared to manufacturer claims, with most published evidence coming from in vitro SNARE complex inhibition assays rather than controlled clinical trials. It is widely available in cosmetic formulations globally and does not require regulatory approval for topical cosmetic use.
Key Published Findings
In vitro studies demonstrate that SNAP-8 inhibits SNARE complex assembly by competing with SNAP-25 (Synaptosomal-Associated Protein of 25 kDa) for incorporation into the exocytosis machinery. Catecholamine release assays in chromaffin cells show dose-dependent reduction in vesicular fusion and neurotransmitter release at relevant peptide concentrations. The eight-amino acid sequence provides enhanced stability and potentially greater SNARE complex affinity compared to the shorter six-amino acid Argireline sequence.
Safety Profile
SNAP-8 has an excellent safety profile for topical application, with no systemic absorption concerns at cosmetic concentrations and no reported sensitization or irritation in patch testing studies. Unlike injectable botulinum toxin, topical SNAP-8 cannot produce muscle paralysis, ptosis, or other serious adverse effects associated with neuromuscular blockade. It is considered suitable for sensitive skin and periorbital use, with no reported phototoxicity or photoallergic reactions.
Comparison to Related Compounds
SNAP-8 is an elongated version of Argireline (Acetyl Hexapeptide-3), with two additional amino acids theoretically providing greater potency and stability in SNARE complex inhibition. Both peptides target the same mechanism but cannot replicate the complete muscle paralysis achieved by botulinum toxin injection, offering instead a modest reduction in muscle contraction intensity. Compared to Matrixyl which stimulates collagen production, SNAP-8 addresses a completely different aspect of aging (dynamic wrinkles vs. structural collagen loss) and the two are complementary in formulations.
Community Observations
Skincare communities generally report subtle but noticeable improvements in forehead lines and crow's feet with consistent use over 4-8 weeks. Users frequently note that SNAP-8 works best as part of a comprehensive anti-aging routine rather than as a standalone treatment, managing expectations relative to injectable alternatives. DIY skincare formulators commonly work with SNAP-8 solutions at 3-10% concentration, noting that higher concentrations do not necessarily produce proportionally better results.
半減期
N/A (topical)
再構成
N/A (topical formulation)
保存
乾燥粉末
Room temperature. Protect from light.
再溶解
Store at room temperature. Stable in formulation for 12+ months.
米国法的状況
また知られる名前
よくある質問
Snap-8とは何ですか?
SNAP-8 (Acetyl Octapeptide-3, also marketed as Acetyl Glutamyl Heptapeptide-1) is a topical cosmetic peptide consisting of eight amino acids that modulates the SNARE complex responsible for neurotransmitter release at the neuromuscular junction. Developed by Lipotec as an extension of the hexapeptide Argireline concept, SNAP-8 is marketed as a topical alternative to botulinum toxin for reducing expression lines and wrinkles. It competitively inhibits SNARE complex formation, theoretically reducing muscle contraction intensity and thereby diminishing dynamic wrinkles.
Snap-8はどのように作用しますか?
Octapeptide that mimics the N-terminal of SNAP-25, a key protein in the SNARE complex responsible for neurotransmitter release at neuromuscular junctions. Competitively inhibits SNARE complex formation, reducing muscle contraction intensity and thereby reducing expression lines.
Snap-8の米国での規制状況は?
Cosmetic ingredient (unregulated)
Snap-8の半減期は?
N/A (topical)
Snap-8の別名は?
Acetyl Octapeptide-3, SNAP-8 Peptide
ペプチドコンタクトは、研究目的のみのための要約情報を提供しています。私たちはベンダーの文書をホスト、配布、または推奨していません。すべての分析証明書、GMP認定証明書、およびベンダーコミュニケーションは、購入者によって直接要求され、確認される必要があります。このプラットフォーム上の何らかの情報は法的、医学的、または専門的なアドバイスを構成していません。ユーザーは、適切な法律、州法、および連邦法に準拠するためにベンダー資格を検証し、購入前に遵守することに全責任を持つ必要があります。このプラットフォームを使用することで、完全な個人的責任を承認することになります。
完全な免責事項を読む